Explanation of Figures, Section 2: ART Cycles Using
Fresh, Nondonor Eggs or Embryos
This
page contains figures 16–26 of Section 2B
Click on titles or images to go back to Section 2B
Figure 16 is a line graph representing the percentages of ART
cycles using fresh nondonor eggs or embryos that resulted in
miscarriage, by age of woman, 2005.
• Age <25, 10.0%
• Age 25, 11.2%
• Age 26, 12.1%
• Age 27, 9.1%
• Age 28, 9.5%
• Age 29, 10.6%
• Age 30, 10.5%
• Age 31, 10.4%
• Age 32, 10.6%
• Age 33, 13.0%
• Age 34, 13.3%
• Age 35, 13.5%
• Age 36, 14.8%
• Age 37, 17.8%
• Age 38, 21.4%
• Age 39, 23.4%
• Age 40, 27.1%
• Age 41, 33.1%
• Age 42, 40.0%
• Age 43, 43.1%
• Age >43, 64.2%

Figure 17 is a line graph with four lines representing the
percentages of pregnancies that continued past a given gestational week
among women who had ART cycles using fresh nondonor eggs or embryos, by
age of woman, 2005.
• Age <35, Gestational Week 4, 100%
• Age <35, Gestational Week 6, 99.2%
• Age <35, Gestational Week 8, 95.3%
• Age <35, Gestational Week 10, 91.9%
• Age <35, Gestational Week 12, 90.6%
• Age <35, Gestational Week 14, 90.1%
• Age <35, Gestational Week 16, 89.7%
• Age <35, Gestational Week 18, 89.1%
• Age <35, Gestational Week 20, 88.4%
• Age <35, Gestational Week 22, 87.7%
• Age <35, Gestational Week 24, 87.2%
• Age 35–37, Gestational Week 4, 100%
• Age 35–37, Gestational Week 6, 98.9%
• Age 35–37, Gestational Week 8, 93.7%
• Age 35–37, Gestational Week 10, 88.7%
• Age 35–37, Gestational Week 12, 86.8%
• Age 35–37, Gestational Week 14, 86.1%
• Age 35–37, Gestational Week 16, 85.7%
• Age 35–37, Gestational Week 18, 85.2%
• Age 35–37, Gestational Week 20, 84.4%
• Age 35–37, Gestational Week 22, 83.7%
• Age 35–37, Gestational Week 24, 83.2%
• Age 38–40, Gestational Week 4, 100%
• Age 38–40, Gestational Week 6, 98.8%
• Age 38–40, Gestational Week 8, 90.1%
• Age 38–40, Gestational Week 10, 81.4%
• Age 38–40, Gestational Week 12, 78.8%
• Age 38–40, Gestational Week 14, 77.8%
• Age 38–40, Gestational Week 16, 77.2%
• Age 38–40, Gestational Week 18, 76.2%
• Age 38–40, Gestational Week 20, 75.7%
• Age 38–40, Gestational Week 22, 75.1%
• Age 38–40, Gestational Week 24, 74.7%
• Age 41–42, Gestational Week 4, 100%
• Age 41–42, Gestational Week 6, 97.9%
• Age 41–42, Gestational Week 8, 84.1%
• Age 41–42, Gestational Week 10, 71.6%
• Age 41–42, Gestational Week 12, 66.2%
• Age 41–42, Gestational Week 14, 64.6%
• Age 41–42, Gestational Week 16, 63.7%
• Age 41–42, Gestational Week 18, 62.8%
• Age 41–42, Gestational Week 20, 62.1%
• Age 41–42, Gestational Week 22, 61.6%
• Age 41–42, Gestational Week 24, 61.2%
• Age >42, Gestational Week 4, 100%
• Age >42, Gestational Week 6, 97.3%
• Age >42, Gestational Week 8, 76.1%
• Age >42, Gestational Week 10, 56.5%
• Age >42, Gestational Week 12, 51.0%
• Age >42, Gestational Week 14, 47.8%
• Age >42, Gestational Week 16, 47.6%
• Age >42, Gestational Week 18, 46.4%
• Age >42, Gestational Week 20, 45.7%
• Age >42, Gestational Week 22, 45.4%
• Age >42, Gestational Week 24, 45.2%

Figure 18 is a bar graph representing outcomes of ART cycles
using fresh nondonor eggs or embryos, by stage and age group, 2005.
• Age <35, Retrieval 92%, Transfer 86%, Pregnancy 43%, Live birth 37%
• Age 35–37, Retrieval 88%, Transfer 82%, Pregnancy 36%, Live birth 29%
• Age 38–40, Retrieval 85%, Transfer 78%, Pregnancy 27%, Live birth 20%
• Age 41–42, Retrieval 81%, Transfer 71%, Pregnancy 18%, Live birth 11%
• Age >42, Retrieval 78%, Transfer 64%, Pregnancy 8%, Live birth 4%

Figure 19 is a pie chart representing diagnoses among couples
who had ART cycles using fresh nondonor eggs or embryos, 2005. Note:
Total does not equal 100% due to rounding.
• Tubal factor, 10.6%
• Ovulatory dysfunction, 6.1%
• Diminished ovarian reserve, 8.2%
• Endometriosis, 5.6%
• Uterine factor, 1.5%
• Male factor, 18.3%
• Other cause, 7.2%
• Unexplained cause, 12.2%
• Multiple factors, female only, 11.7%
• Multiple factors, female + male, 18.5%

Figure 20 is a bar graph representing the percentages of ART
cycles using fresh nondonor eggs or embryos that resulted in live
births, by diagnosis, 2005.
• Tubal factor, 29.1%
• Ovulatory dysfunction, 34.4%
• Diminished ovarian reserve, 14.5%
• Endometriosis, 32.2%
• Uterine factor, 23.6%
• Male factor, 33.5%
• Other cause, 24.3%
• Unexplained cause, 30.4%
• Multiple factors – female only, 23.7%
• Multiple factors – female + male, 26.1%

Figure 21 is a pie chart representing the number of previous
births among women who had ART cycles using fresh nondonor eggs or embryos,
2005. Note: Total does not equal 100% due to rounding.
• None, 71.9%
• One, 20.5%
• Two, 4.8%
• Three or more, 2.7%

Figure 22 is a bar graph representing the percentages of ART
cycles using fresh nondonor eggs or embryos that resulted in live
births, by woman’s age and number of previous live births, 2005.
• Age <35, No previous live births 36.4%, 1 or more previous live births
40.3%
• Age 35–37, No previous live births 28.6%, 1 or more previous live
births 31.4%
• Age 38–40, No previous live births 18.8%, 1 or more previous live
births 21.6%
• Age 41–42, No previous live births 9.9%, 1 or more previous live
births 11.9%
• Age >42, No previous live births 3.2%, 1 or more previous live births
4.7%
Figure 23 is a bar graph representing the percentages of ART
cycles using fresh nondonor eggs or embryos that resulted in live
births, by woman’s age and history of miscarriage, among women with no
previous births, 2005. Note: Women reporting only previous ectopic
pregnancies or pregnancies that ended in induced abortion were not
included in these statistics.
• Age <35, No previous pregnancies 36.7%, 1 or more previous
miscarriages 35.7%
• Age 35–37, No previous pregnancies 28.2%, 1 or more previous
miscarriages 29.4%
• Age 38–40, No previous pregnancies 18.4%, 1 or more previous
miscarriages 19.5%
• Age 41–42, No previous pregnancies 9.5%, 1 or more previous
miscarriages 10.4%
• Age >42, No previous pregnancies 3.2%, 1 or more previous miscarriages
3.2%
Figure 24 is a pie chart representing the number of previous ART
cycles among women undergoing ART in 2005 with fresh nondonor eggs or
embryos.
• Zero, 57.2%
• One, 19.7%
• Two, 10.8%
• Three, 5.7%
• Four or more, 6.6%
Figure 25 is a bar graph representing the percentages of ART
cycles using fresh nondonor eggs or embryos that resulted in live
births, by woman’s age and history of previous ART cycles, among women
with no previous births, 2005.
• Age <35, No previous ART and no previous births 38.5%, 1 or more
previous ART cycles and no previous births 32.0%
• Age 35–37, No previous ART and no previous births 30.0%, 1 or more
previous ART cycles and no previous births 26.4%
• Age 38–40, No previous ART and no previous births 19.9%, 1 or more
previous ART cycles and no previous births 17.4%
• Age 41–42, No previous ART and no previous births 10.1%, 1 or more
previous ART cycles and no previous births 9.7%
• Age >42, No previous ART and no previous births 2.8%, 1 or more
previous ART cycles and no previous births 3.5%
Figure 26 is a bar graph representing the percentages of ART
cycles using fresh nondonor eggs or embryos that resulted in live
births, by woman’s age and history of previous ART cycles, among women
with one or more previous birth, 2005.
• Age <35, No previous ART and 1 or more previous births 40.9%, 1 or
more previous ART cycles and 1 or more previous births 39.8%
• Age 35–37, No previous ART and 1 or more previous births 32.8%, 1 or
more previous ART cycles and 1 or more previous births 30.2%
• Age 38–40, No previous ART and 1 or more previous births 22.8%, 1 or
more previous ART cycles and 1 or more previous births 20.8%
• Age 41–42, No previous ART and 1 or more previous births 11.3%, 1 or
more previous ART cycles and 1 or more previous births 12.4%
• Age >42, No previous ART and 1 or more previous births 3.8%, 1 or more
previous ART cycles and 1 or more previous births 5.3%
Section
1 | Section 2 |
Section
3 | Section 4 |
Section
5
Previous ART Reports
Implementation
of the Fertility Clinic Success Rate and Certification Act of 1992
Assisted
Reproductive Technology: Embryo Laboratory
Page last reviewed: 12/12/07
Page last modified: 12/12/07
Content source: Division
of Reproductive Health,
National Center for Chronic Disease
Prevention and Health Promotion